z-logo
open-access-imgOpen Access
Lung cancer prediction from microarray data by gene expression programming
Author(s) -
Azzawi Hasseeb,
Hou Jingyu,
Xiang Yong,
Alanni Russul
Publication year - 2016
Publication title -
iet systems biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.367
H-Index - 50
eISSN - 1751-8857
pISSN - 1751-8849
DOI - 10.1049/iet-syb.2015.0082
Subject(s) - lung cancer , feature selection , microarray analysis techniques , support vector machine , computer science , perceptron , cross validation , multilayer perceptron , machine learning , artificial intelligence , data mining , microarray , artificial neural network , receiver operating characteristic , gene , biology , gene expression , medicine , oncology , biochemistry
Lung cancer is a leading cause of cancer‐related death worldwide. The early diagnosis of cancer has demonstrated to be greatly helpful for curing the disease effectively. Microarray technology provides a promising approach of exploiting gene profiles for cancer diagnosis. In this study, the authors propose a gene expression programming (GEP)‐based model to predict lung cancer from microarray data. The authors use two gene selection methods to extract the significant lung cancer related genes, and accordingly propose different GEP‐based prediction models. Prediction performance evaluations and comparisons between the authors’ GEP models and three representative machine learning methods, support vector machine, multi‐layer perceptron and radial basis function neural network, were conducted thoroughly on real microarray lung cancer datasets. Reliability was assessed by the cross‐data set validation. The experimental results show that the GEP model using fewer feature genes outperformed other models in terms of accuracy, sensitivity, specificity and area under the receiver operating characteristic curve. It is concluded that GEP model is a better solution to lung cancer prediction problems.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here